SD 1 d404873dsd.htm FORM SD Form SD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM SD

 

 

Specialized Disclosure Report

Commission File Number: 000-52607

 

 

Universal Biosensors, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   98-0424072

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

Universal Biosensors, Inc.

1 Corporate Avenue,

Rowville, 3178, Victoria

Australia

  Not Applicable
(Address of principal executive offices)   (Zip Code)

Telephone: +61 3 9213 9000

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

 

  Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2016

 

 

 


Section 1 - Conflict Minerals Disclosure

Item 1.01 Conflict Minerals Disclosure and Report

Conflict Minerals Disclosure

This report contains disclosure provided pursuant to Rule 13p-1 under the Exchange Act (the “Rule”), requiring every registrant that files reports with the Commission under Sections 13(a) or 15(d) of the Exchange Act, having conflict minerals that are necessary to the functionality or production of a product manufactured or contracted by that registrant to be manufactured, to file a report on Form SD. The Rule was mandated by the Dodd Frank Wall Street Reform and Consumer Protection Act of 2010 in an effort to curb violence and human rights abuses in the Democratic Republic of the Congo and adjoining countries (“Covered Countries”) because conflict minerals were believed to be financing the conflict in the Covered Countries.

The Rule defines conflict minerals as gold, columbite-tantalite (coltan), cassiterite, and wolframite, including their derivatives tantalum, tin, and tungsten. While these minerals have been identified as being used to finance conflict in the Covered Countries, the use of any of these minerals in a product does not necessarily mean that it is financing conflict in the Covered Countries. The Rule requires issuers to determine and to disclose annually whether the minerals that are necessary to the functionality or production of a product manufactured by such issuer originated in the Covered Countries.

Our Conflict Minerals Policy and Procedures

We have adopted a Conflict Minerals Policy that expresses our desire to assist in ending human rights violations in the mining of certain minerals that finance conflict in the Democratic Republic of the Congo and adjoining countries. Pursuant to this policy, we are committed to sourcing components and materials from companies that share our values regarding respect for human rights, integrity and environmental responsibility.

In carrying out our policy, we consider the guidance in the OECD Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas published by the Organization of Economic Cooperation and Development. To ensure compliance with this guidance, we ask our suppliers to undertake reasonable due diligence with their supply chains to assure that specified metals are being sourced only from:

 

    Mines and smelters outside the Covered Countries or

 

    Mines and smelters which have been certified by an independent third party as conflict free if sourced within the Covered Countries.

The initial phase of our due diligence involves reaching out to our suppliers and understanding where they acquire the materials they provide us. We require that our suppliers provide us with completed EICC-GeSI declarations evidencing that raw materials used to produce gold, tin, tantalum and tungsten, used in the materials to manufacture components and products supplied to UBI, originate from outside the Covered Countries or if they originate from within the Covered Countries, that the mines or smelters be certified as conflict free by an independent third party. In obtaining these declarations from our suppliers, we use the conflict minerals reporting template released by the Electronic Industry Citizenship Coalition (EICC), a coalition of electronics companies, and the Global e-Sustainability Initiative (GeSI), a sustainability-oriented organization focused on the information and communication technology industries.


Upon receipt of these declarations, we review the responses to determine whether each supplier’s representations appear to be accurate. We consider all facts and circumstances related to each supplier’s representations. One factor that we consider is whether the smelter or mine that the supplier identifies as the source of the minerals is outside the Covered Countries. If a smelter or mine was in the Covered Countries, we would consider whether the smelter or mine is on the EICC-GeSI published list of smelters or mines that have been certified by an independent third party audit to be conflict free. Other factors may include whether any of the minerals are from recycled or scrap resources and whether the suppliers are known to do business in the Covered Countries.

If we believe that the minerals supplied to us originate in the Covered Countries or may have originated therein, we will conduct further diligence on our supply chain to determine whether the minerals originated in the Covered Countries. In conducting such a diligence inquiry, we would follow the OECD Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas.

Our Website

We also publish our annual Conflict Minerals Disclosure and our Conflict Minerals Policy on our website at http://www.universalbiosensors.com/Investor-Centre/Corporate-Governance.aspx

Our Review for the Fiscal Year Ended December 31, 2016

Upon a review of our products, we determined that we use gold in strips. Universal Biosensors is a specialist medical diagnostics company focused on the development, manufacture and commercialization of a range of in vitro diagnostic tests for point-of-care use. In vitro diagnostic testing involves the testing of a body fluid or tissue sample outside the body. The diagnostic tests comprise a disposable test strip and a reusable meter. The diagnostic tests are small, portable and designed to be easy-to-use. The electrochemical cell in the test strip is designed to allow for greater accuracy while retaining other critical features including the ability to obtain results quickly using only a small finger prick sample of blood. The process for manufacturing the test strips is designed to be economical and capitalizes on the use of commercially available materials.

We obtain the gold we use in our strips from a single supplier. The supplier provided us with information regarding its supply chain according to the EICC-GeSI template described above. Upon careful review of the supplier’s responses, and all information that we have obtained regarding the supplier in the normal course of our business with the supplier, we determined that the gold used in our strips did not originate in the Covered Countries. We believe that our country of origin inquiry as described in this report is reasonable and provides an adequate basis for our conclusion.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

 

 

            UNIVERSAL BIOSENSORS, INC.

                                 (Registrant)

Date: May 25, 2017  

/s/ Andrew Denver

  By:   Andrew Denver
    Principal Executive Officer

 

Date: May 25, 2017  

/s/ Salesh Balak

  By:   Salesh Balak
    Principal Financial Officer